当前位置:首页 - 行情中心 - 共同药业(300966) - 财务分析 - 现金流量表

共同药业

(300966)

  

流通市值:17.19亿  总市值:25.95亿
流通股本:7636.82万   总股本:1.15亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金371,928,026.42187,423,903.0787,260,458.57451,575,401.16
  收到的税费返还30,885,953.9927,173,040.1111,352,219.768,146,056.57
  收到其他与经营活动有关的现金9,355,868.648,253,422.638,555,572.46116,630,481.96
  经营活动现金流入小计412,169,849.05222,850,365.81107,168,250.73636,351,939.69
  购买商品、接受劳务支付的现金291,918,645.29143,903,659.3392,244,522.07517,457,150.25
  支付给职工以及为职工支付的现金64,452,964.744,200,351.1523,247,367.3367,227,772.45
  支付的各项税费16,621,189.515,757,437.997,888,354.3720,895,272.39
  支付其他与经营活动有关的现金45,343,057.9224,781,812.1712,562,288.4951,360,192.23
  经营活动现金流出小计418,335,857.41228,643,260.64135,942,532.26656,940,387.32
  经营活动产生的现金流量净额-6,166,008.36-5,792,894.83-28,774,281.53-20,588,447.63
二、投资活动产生的现金流量:
  收回投资收到的现金-0--
  取得投资收益收到的现金-0--
  处置固定资产、无形资产和其他长期资产收回的现金净额133,709133,709133,309118,400
  处置子公司及其他营业单位收到的现金净额-0--
  收到的其他与投资活动有关的现金---17,157,465.13
  投资活动现金流入小计133,709133,709133,30917,275,865.13
  购建固定资产、无形资产和其他长期资产支付的现金141,243,927.94115,639,950.7782,259,738.98311,613,852.76
  投资支付的现金-0--
  质押贷款净增加额-0--
  取得子公司及其他营业单位支付的现金-0--
  支付其他与投资活动有关的现金-0--
  投资活动现金流出小计141,243,927.94115,639,950.7782,259,738.98311,613,852.76
  投资活动产生的现金流量净额-141,110,218.94-115,506,241.77-82,126,429.98-294,337,987.63
三、筹资活动产生的现金流量:
  吸收投资收到的现金-0-24,500,000
  其中:子公司吸收少数股东投资收到的现金-0-24,500,000
  取得借款收到的现金364,787,491.18250,918,608.07123,931,436.69723,589,646.66
  收到其他与筹资活动有关的现金49,013,137.6629,110,776.559,934,277.7832,001,500
  筹资活动现金流入小计413,800,628.84280,029,384.62133,865,714.47780,091,146.66
  偿还债务支付的现金217,740,000148,390,00033,020,000434,195,867.85
  分配股利、利润或偿付利息支付的现金15,753,048.69,576,063.122,901,455.8525,692,538.29
  其中:子公司支付给少数股东的股利、利润-0--
  支付其他与筹资活动有关的现金51,734,496.283,030,264.521,921,250.12798,650
  筹资活动现金流出小计285,227,544.88160,996,327.6437,842,705.97460,687,056.14
  筹资活动产生的现金流量净额128,573,083.96119,033,056.9896,023,008.5319,404,090.52
四、汇率变动对现金及现金等价物的影响-43,987.3689,458.955,663.29-561,781.53
五、现金及现金等价物净增加额-18,747,130.7-2,176,620.72-14,822,039.723,915,873.73
  加:期初现金及现金等价物余额100,122,033.02100,122,033.02100,122,033.0296,206,159.29
  期末现金及现金等价物余额81,374,902.3297,945,412.385,299,993.3100,122,033.02
补充资料:
  净利润--14,654,445.7--31,656,138.87
  资产减值准备-5,172,986.61-17,547,611.61
  固定资产和投资性房地产折旧-52,265,209.14-42,618,192.09
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-52,265,209.14-42,618,192.09
  无形资产摊销-557,212.56-363,969.88
  长期待摊费用摊销-1,653,769.38-3,307,538.77
  处置固定资产、无形资产和其他长期资产的损失-1,568,177.45--113,563.03
  固定资产报废损失-1,215,637.53-1,481,684.71
  公允价值变动损失--0.07--0.18
  财务费用-23,517,172.44-24,808,489.94
  投资损失-219,416.42-349,407.59
  递延所得税--9,449,316.33--14,947,970.25
  其中:递延所得税资产减少--9,612,189.63--14,669,186.77
    递延所得税负债增加-162,873.3--278,783.48
  存货的减少--55,258,045.83--43,313,376.35
  经营性应收项目的减少--44,878,873.65-8,557,292.44
  经营性应付项目的增加-31,978,578.94--29,828,982.38
  其他-271,275.62--25,205.96
  现金的期末余额-97,945,412.3-100,122,033.02
  减:现金的期初余额-100,122,033.02-96,206,159.29
  现金及现金等价物的净增加额--2,176,620.72-3,915,873.73
公告日期2025-10-282025-08-292025-04-292025-04-24
审计意见(境内)标准无保留意见
TOP↑